Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 8.95
Key Takeaways
Risk factor
Sufficiently resilient to price shocks
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
LanZhou Foci Pharmaceutical Co.,Ltd., a pharmaceutical company, manufactures and sells traditional Chinese medicines in China. It offers its products in various dosage forms, including pills, tablets, capsules, and granules under the Min Shan and Foci brands. The company also engages in researching activities for the development of new herbal drugs. It also exports its products...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI
Data is available to registered users only
Buy
Sell